Home » GeneGo Integrates MetaCore, MetaDrug With Spotfire's DecisionSuite for Drug Discovery

GeneGo Integrates MetaCore, MetaDrug With Spotfire's DecisionSuite for Drug Discovery

Jan 23, 2007
NEW YORK (GenomeWeb News) — GeneGo and Spotfire have integrated their software products for genomics, proteomics, and gene-expression analysis involved in drug development, GeneGo said today.
 
GeneGo’s MetaCore 4.2 is a biomarker-identification and -validation tool, and its MetaDrug platform is used to predict metabolism, toxicity, and the effects of small molecule compounds. Spotfire’s DecisionSuite, meantime, visualizes genomics data.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Informatics

  1. ClinGen Lists Labs Meeting Requirements for Quality Data Sharing on Genetic Variants

    Premium

  2. Tempus, Rush University Medical Center Collaborate to Expand Hospital's Biobank

  3. Thermo Fisher's Oncomine Knowledgebase Reporter Aims to Simplify NGS Analysis

    Premium

  4. Novogene, PacBio to Codevelop Precision Medicine Applications Based on Sequel

  5. Three Firms Team to Offer Genomic Informatics, Cloud Storage, Research Lab

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.